Home » Topics » Regulatory

Regulatory
RSS

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

FDA approves Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Aug. 11, 2015

FDA approves Praluent to treat high LDL cholesterol

July 27, 2015

FDA approves Odomzo for locally advanced BCC

July 27, 2015

Evolocumab becomes first PCSK9 inhibitor approved in the world

July 22, 2015

FDA approves Rexulti for schizophrenia and major depressive disorder

July 13, 2015

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

July 8, 2015

Olanedine antiseptic approved in Japan

July 7, 2015

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015

Acoalan approved in Japan

July 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...